Purple BiotechPPBT
13F holders, Q4 2024 (December 31)1holders
0new positions
0sold out
$4.67avg. 13F price*
At the end of Q4 2024, 1 institutions reported holding Purple Biotech Ltd. (PPBT) in their 13F filings, unchanged from Q3 2024. 0 opened new positions and 0 sold out. The largest holder was North Star Investment Management Corp. ($70).
- Company
- Purple Biotech Ltd.
- CUSIP
- 74638P109
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| North Star Investment Management Corp. | 0.00% | No change | 15 | $70 |
"% of holder's portfolio" is PPBT's weight in each manager's 13F, not the share of Purple Biotech Ltd. the manager owns.